Home › Non-Small Cell Lung Cancer › Pennsylvania › Reading
Non-Small Cell Lung Cancer clinical trials in Reading, PA
9 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Reading (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- McGlinn Cancer Institute Reading Hospital, West Reading · 1 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Reading
- Lung Cancer11 studies
- Acute Myeloid Leukemia5 studies
- Breast Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Prostate Cancer4 studies
- Cancer (all types)4 studies
- Colorectal Cancer3 studies
- Narcolepsy3 studies
- Sleep Disorders3 studies
- Fatigue3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.